Drug intelligence / Profile preview

cortex fraxini

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical/bath Soak/eye Wash
01

Overview

Cortex Fraxini (秦皮; Qin Pi) is the dried inner bark of several species of ash trees in the genus Fraxinus—primarily *Fraxinus rhynchophylla*, *Fraxinus chinensis*, *Fraxinus szaboana*, and *Fraxinus stylosa*. It is a traditional Chinese medicinal herb classified as a "heat-clearing" and "dampness-drying" agent. Cortex Fraxini has been used for over 2,000 years to treat conditions such as diarrhea (especially damp-heat dysentery), bacillary dysentery with tenesmus and abdominal pain, excessive leukorrhea (vaginal discharge), conjunctivitis (red/swollen eyes), cough with phlegm or wheezing due to lung heat, hyperuricemia/gout, and other inflammatory disorders[1][6][7][8]. Phytochemically rich in coumarins (notably esculin, esculetin, fraxin/fraxetin), lignans, secoiridoids, phenolic acids/flavonoids/triterpenoids/steroids[6], Cortex Fraxini exhibits anti-inflammatory[6], antioxidant[3], antibacterial[6], and anti-tumor properties. Modern studies show its active metabolites can regulate cell cycle progression and apoptosis in tumor cells via pathways such as MEK/ERK inhibition and PI3-K/Akt/GSK3β modulation[3][6]. In TCM theory it enters the Gallbladder/Liver/Large Intestine meridians; it is bitter/cold/astringent. It may be used internally or externally.

Other names
qin piash barkfraxinus branch barkfraxinus rhynchophylla barkfraxinus chinensis barkfraxinus szaboana barkfraxinus stylosa bark
02

Targets

ABCG2 (Breast cancer resistance protein)BAX (Apoptosis regulator BAX)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))BCL-2 (BCL-2 family)

Beyond the preview

Go deeper on cortex fraxini.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cortex fraxini.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call